Logo image of INNV

INNOVAGE HOLDING CORP (INNV) Stock Fundamental Analysis

NASDAQ:INNV - Nasdaq - US45784A1043 - Common Stock - Currency: USD

4.09  +0.04 (+0.99%)

After market: 4.18 +0.09 (+2.2%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to INNV. INNV was compared to 102 industry peers in the Health Care Providers & Services industry. INNV may be in some trouble as it scores bad on both profitability and health. INNV is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

INNV had negative earnings in the past year.
In the past year INNV had a positive cash flow from operations.
In the past 5 years INNV reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: INNV reported negative operating cash flow in multiple years.
INNV Yearly Net Income VS EBIT VS OCF VS FCFINNV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

The Return On Assets of INNV (-5.82%) is worse than 71.57% of its industry peers.
With a Return On Equity value of -13.12%, INNV is not doing good in the industry: 62.75% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -5.82%
ROE -13.12%
ROIC N/A
ROA(3y)-4.08%
ROA(5y)-2.82%
ROE(3y)-7.87%
ROE(5y)-2.14%
ROIC(3y)N/A
ROIC(5y)N/A
INNV Yearly ROA, ROE, ROICINNV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

With a Gross Margin value of 17.91%, INNV is not doing good in the industry: 63.73% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of INNV has declined.
INNV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.12%
GM growth 5Y-6.16%
INNV Yearly Profit, Operating, Gross MarginsINNV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

3

2. Health

2.1 Basic Checks

INNV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, INNV has more shares outstanding
Compared to 5 years ago, INNV has more shares outstanding
INNV has a better debt/assets ratio than last year.
INNV Yearly Shares OutstandingINNV Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
INNV Yearly Total Debt VS Total AssetsINNV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 2.15 indicates that INNV is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.15, INNV is in line with its industry, outperforming 48.04% of the companies in the same industry.
The Debt to FCF ratio of INNV is 4.81, which is a neutral value as it means it would take INNV, 4.81 years of fcf income to pay off all of its debts.
INNV has a better Debt to FCF ratio (4.81) than 68.63% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that INNV is not too dependend on debt financing.
INNV has a better Debt to Equity ratio (0.04) than 78.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 4.81
Altman-Z 2.15
ROIC/WACCN/A
WACC8.35%
INNV Yearly LT Debt VS Equity VS FCFINNV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.78 indicates that INNV may have some problems paying its short term obligations.
INNV has a worse Current ratio (0.78) than 80.39% of its industry peers.
A Quick Ratio of 0.78 indicates that INNV may have some problems paying its short term obligations.
INNV's Quick ratio of 0.78 is on the low side compared to the rest of the industry. INNV is outperformed by 73.53% of its industry peers.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.78
INNV Yearly Current Assets VS Current LiabilitesINNV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.27% over the past year.
Looking at the last year, INNV shows a quite strong growth in Revenue. The Revenue has grown by 12.18% in the last year.
INNV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.41% yearly.
EPS 1Y (TTM)27.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)12.18%
Revenue growth 3Y6.2%
Revenue growth 5Y10.41%
Sales Q2Q%12.99%

3.2 Future

Based on estimates for the next years, INNV will show a very strong growth in Earnings Per Share. The EPS will grow by 52.26% on average per year.
The Revenue is expected to grow by 11.88% on average over the next years. This is quite good.
EPS Next Y-78.5%
EPS Next 2Y53.76%
EPS Next 3Y52.26%
EPS Next 5YN/A
Revenue Next Year12.78%
Revenue Next 2Y11.76%
Revenue Next 3Y11.88%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
INNV Yearly Revenue VS EstimatesINNV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
INNV Yearly EPS VS EstimatesINNV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -5 -10 -15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

INNV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 80.20 indicates a quite expensive valuation of INNV.
INNV's Price/Forward Earnings is on the same level as the industry average.
INNV's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.15.
Industry RankSector Rank
PE N/A
Fwd PE 80.2
INNV Price Earnings VS Forward Price EarningsINNV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

INNV's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 34.53
EV/EBITDA N/A
INNV Per share dataINNV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

INNV's earnings are expected to grow with 52.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.76%
EPS Next 3Y52.26%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for INNV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INNOVAGE HOLDING CORP

NASDAQ:INNV (5/30/2025, 8:05:18 PM)

After market: 4.18 +0.09 (+2.2%)

4.09

+0.04 (+0.99%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)09-08 2025-09-08/amc
Inst Owners11.86%
Inst Owner Change1.47%
Ins Owners1.54%
Ins Owner Change0.05%
Market Cap552.19M
Analysts48
Price Target5.95 (45.48%)
Short Float %1.42%
Short Ratio5.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-409.8%
Min EPS beat(2)-527.45%
Max EPS beat(2)-292.16%
EPS beat(4)1
Avg EPS beat(4)-190.35%
Min EPS beat(4)-527.45%
Max EPS beat(4)62.77%
EPS beat(8)2
Avg EPS beat(8)-120.73%
EPS beat(12)3
Avg EPS beat(12)-113.22%
EPS beat(16)4
Avg EPS beat(16)-99.95%
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-2.58%
Max Revenue beat(2)-0.1%
Revenue beat(4)1
Avg Revenue beat(4)-0.42%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)2.09%
Revenue beat(8)4
Avg Revenue beat(8)-0.15%
Revenue beat(12)4
Avg Revenue beat(12)-1.01%
Revenue beat(16)6
Avg Revenue beat(16)-0.45%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-650.75%
EPS NQ rev (3m)-650.75%
EPS NY rev (1m)-98.65%
EPS NY rev (3m)-145%
Revenue NQ rev (1m)0.46%
Revenue NQ rev (3m)0.46%
Revenue NY rev (1m)0.58%
Revenue NY rev (3m)0.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 80.2
P/S 0.66
P/FCF 34.53
P/OCF 21.45
P/B 2.32
P/tB 6.01
EV/EBITDA N/A
EPS(TTM)-0.16
EYN/A
EPS(NY)0.05
Fwd EY1.25%
FCF(TTM)0.12
FCFY2.9%
OCF(TTM)0.19
OCFY4.66%
SpS6.16
BVpS1.76
TBVpS0.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.82%
ROE -13.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.91%
FCFM 1.92%
ROA(3y)-4.08%
ROA(5y)-2.82%
ROE(3y)-7.87%
ROE(5y)-2.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.12%
GM growth 5Y-6.16%
F-Score6
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 4.81
Debt/EBITDA N/A
Cap/Depr 45.45%
Cap/Sales 1.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.78
Altman-Z 2.15
F-Score6
WACC8.35%
ROIC/WACCN/A
Cap/Depr(3y)155.97%
Cap/Depr(5y)146.35%
Cap/Sales(3y)3.3%
Cap/Sales(5y)3.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-78.5%
EPS Next 2Y53.76%
EPS Next 3Y52.26%
EPS Next 5YN/A
Revenue 1Y (TTM)12.18%
Revenue growth 3Y6.2%
Revenue growth 5Y10.41%
Sales Q2Q%12.99%
Revenue Next Year12.78%
Revenue Next 2Y11.76%
Revenue Next 3Y11.88%
Revenue Next 5YN/A
EBIT growth 1Y17.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year232.96%
EBIT Next 3Y74.52%
EBIT Next 5YN/A
FCF growth 1Y162.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y149.16%
OCF growth 3YN/A
OCF growth 5YN/A